Infringement Has Judge's Eye In Ferring-Serenity Remote Trial
Law360 (July 14, 2020, 11:12 PM EDT) -- The New York federal judge overseeing a Zoom bench trial between drugmakers Ferring and Serenity over a pair of patents relating to nighttime urination medication told the parties Tuesday that she finds Serenity's infringement allegations "infinitely more interesting" than Ferring's claims to invalidate the patents.
Ferring Pharmaceuticals is seeking to invalidate two Serenity Pharmaceuticals patents relating to the use of the anti-diuretic compound desmopressin, and Serenity has counterclaimed that Ferring's drug Nocdurna infringes those patents.
During the second week of the patent showdown being held remotely before Chief U.S. District Judge Colleen McMahon of the Southern District of New York, the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!